Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacokinetic interactions with rifampicin.

W Zilly, D D Breimer, E Richter

    Clinical Pharmacokinetics
    |January 1, 1977
    PubMed
    Summary

    Rifampicin, an antituberculosis drug, can interact with other medications. It may decrease absorption of some drugs and speed up the metabolism of others, affecting treatment efficacy.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Site specific rectal drug administration in man with an osmotic system: influence on "first-pass" elimination of lidocaine.

    Pharmaceutical research·2013
    Same author

    Avoidance of "first-pass" elimination of rectally administered propranolol in relation to the site of absorption in rats.

    Pharmaceutical research·2013
    Same author

    Correlation between in vivo antipyrine metabolite formation and theophylline metabolism in rats.

    Pharmaceutical research·2013
    Same author

    The metabolic formation of N-acetyl-S-2-hydroxyethyl-L-cysteine from tetradeutero-1,2-dibromoethane. relative importance of oxidation and glutathione conjugation in vivo.

    Biochemical pharmacology·2010
    Same author

    P-glycoprotein inhibition leads to enhanced disruptive effects by anti-microtubule cytostatics at the in vitro blood-brain barrier.

    Pharmaceutical research·2001
    Same author

    Active efflux of the 5-HT(1A) receptor agonist flesinoxan via P-glycoprotein at the blood-brain barrier.

    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2001

    Area of Science:

    • Pharmacology
    • Clinical Medicine
    • Drug Metabolism

    Background:

    • Rifampicin is a key antituberculosis agent often used with other drugs.
    • Potential for significant drug interactions exists due to long treatment durations and polypharmacy.

    Purpose of the Study:

    • To investigate the drug interaction profile of rifampicin.
    • To understand how rifampicin affects the absorption and metabolism of co-administered drugs.

    Main Methods:

    • Review of clinical observations and investigations on rifampicin interactions.
    • Analysis of rifampicin's effect on the metabolism of various compounds (e.g., oral anticoagulants, contraceptive pill, digitoxin).
    • Assessment of rifampicin's impact on hepatic drug metabolism enzymes like cytochrome P450.

    Main Results:

    • Para-aminosalicylic acid granules reduce rifampicin absorption via adsorption.
    • Rifampicin accelerates the metabolism of oral anticoagulants, contraceptive pills, oral hypoglycemic agents, and digitoxin.
    • Rifampicin induces drug metabolism, increasing clearance of hexobarbitone and tolbutamide, but not antipyrine, indicating selective enzyme induction.
    • Probenecid increases rifampicin serum levels, likely by inhibiting hepatic uptake.

    Conclusions:

    • Rifampicin exhibits significant drug-drug interaction potential, affecting both its own pharmacokinetics and those of other drugs.
    • Understanding these interactions is crucial for optimizing tuberculosis treatment and managing concurrent therapies.
    • Rifampicin's role as a potent inducer of drug metabolism requires careful consideration in clinical practice.

    Related Experiment Videos